poisar

Stocks · News reference

Goldman Sachs Maintains Buy on Praxis Precision Medicine, Raises Price Target to $575

Aug 21, 2026, 5:52 PMBenzinga Newsdesk

Goldman Sachs analyst Kevin Strang maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $470 to $575.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

PRAX
Source
benzinga
Observed
Aug 21, 2026, 5:52 PM
Checked
Aug 21, 2026, 5:52 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading